Generate a tailored SOP for Dr. Marcin Imielinski. Improve your application with a focused, well-structured draft.
Marcin Imielinski is an Associate Professor at the Perlmutter Cancer Center, New York University. His research primarily focuses on the clinical utility of whole genome sequencing in oncology, emphasizing the development of software for analyzing and interpreting whole genomes. His laboratory explores the biological and therapeutic implications of complex, noncoding, structural DNA variations in cancer. He has developed methods for genome analysis that have led to the identification of new classes of somatic mutational processes, with notable publications in prestigious journals such as Cell and Nature Genetics. His work includes characterizing structural genomic alterations related to telomere crisis and homologous recombination deficiency, and he is investigating the impact of cancer structural DNA variants on genome folding. His efforts have also led to the development of long-read sequencing assays designed to study high-order 3D interactions in human cells.
Open Program in Biomedical Sciences (Vilcek Institute) covers departments like Biochemistry, Pathology, Neuroscience, Microbiology, etc.